HIV's effect on white blood cells questioned by new researchMay 22, 2007Scientists have refuted a longstanding theory of how HIV slowly depletes the body's capacity to fight infection, in new research published today. The researchers were looking at T helper cells, a class of white blood cells which recognise infection and co-ordinate the body's immune defences. They are attacked by HIV, and their numbers gradually decline in HIV positive patients. It has long been a major puzzle why this process of depletion is so slow, often taking 10 years or more. One popular theory has been the "runaway" hypothesis, which says that T cells infected by HIV produce more HIV virus particles, which activate more T cells, that in turn become infected, leading to an uncontrolled cycle of T cell activation, infection, HIV production and cell destruction.
However, today's new study in PLoS Medicine shows that this theory cannot explain the very slow pace of depletion that occurs in HIV infection. The research team used a mathematical model of the processes by which T cells are produced and eliminated to show that if the runaway theory was correct, then T helper cell numbers would fall to very low levels over a number of months, not years. One of the paper's authors is Jaroslav Stark, Professor of Mathematics at Imperial College London, and Director of the Centre of Integrative Systems Biology at Imperial. He said: "Scientists have never had a full understanding of the processes by which T helper cells are depleted in HIV, and therefore they've been unable to fully explain why HIV destroys the body's supply of these cells at such a slow rate. Our new interdisciplinary research has thrown serious doubt on one popular theory of how HIV affects these cells, and means that further studies are required to understand the mechanism behind HIV's distinctive slow process of cellular destruction." The research team think that one possible explanation could be that the virus slowly adapts itself over the course of the infection, but they stress that further analysis is needed to verify this alternative theory. Professor Stark adds: "If the specific process by which HIV depletes this kind of white blood cells can be identified, it could pave the way for potential new approaches to treatment." Imperial College London | |||||||||||||||||||||
|
Related HIV News Articles Neutral HIV presentations more likely to be considered inviting, study finds A recent study by University of Illinois professor of psychology Dolores Albarracín and her colleagues at the University of Florida and the Alachua County Health Department in Florida found a method to increase enrollment among high-risk individuals in HIV prevention programs. Gene enhancer in evolution of human opposable thumb Scientists have discovered a gene enhancer, known as HACNS1, that may have contributed to the evolution of the uniquely opposable human thumb, and possibly also modifications in the ankle or foot that allow humans to walk on two legs. New nano device detects immune system cell signaling Scientists have detected previously unnoticed chemical signals that individual cells in the immune system use to communicate with each other over short distances. Nature inspires new highly specific drugs and organic products The best place to seek novel compounds for pharmaceutical drugs, alternative energy sources, and a host of industrial applications, is within natural systems that have evolved over millions of years. Scientists develop new method to investigate origin of life Scientists at Penn State have developed a new computational method that they say will help them to understand how life began on Earth. Risk of fracture is significantly higher in HIV-infected patients As antiviral treatment for HIV infection allows patients to live longer, many will be confronted with additional health challenges. A new study shows for the first time that one of these may be significantly increased risk of bone fractures. NIAID describes challenges, prospects for an HIV vaccine Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily challenging properties of the virus that have made a vaccine elusive and outline the scientific questions that, if answered, could lead to an effective HIV vaccine. Study reveals gap in HIV testing knowledge among college students Most college students understand how they can prevent the transmission of HIV but are less knowledgeable about HIV testing, according to a new University of Georgia study. Iowa State University researcher shows proteins have controlled motions Iowa State University researcher Robert Jernigan believes that his research shows proteins have controlled motions. HIV patients at greater risk for bone fractures HIV-infected patients have a higher prevalence of fractures than non HIV-infected patients, across both genders and critical fracture sites according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). More HIV News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||